Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators
Eur Urol
.
2008 Oct;54(4):948-9.
doi: 10.1016/j.eururo.2008.07.026.
Authors
Shahrokh F Shariat
1
,
Christian Bolenz
,
Pierre I Karakiewicz
Affiliation
1
University of Texas Southwestern, Dallas, TX, USA. Shahrokh.Shariat@UTSouthwestern.edu
PMID:
18953756
DOI:
10.1016/j.eururo.2008.07.026
No abstract available
Publication types
Comment